Positive results from early trial of drug that could protect brain cells
Date
Research news
Date
An app for people with Parkinson’s to remotely monitor and manage their non-motor symptoms is now entering the testing phase.
Date
Treatments targeting a protein called LRRK2 are currently being tested in clinical trials for Parkinson's. Researchers hope they may have the ability to slow the progression of the condition which is something no current treatment can do.
Date
Researchers at Queen Mary University of London have reported results from the first UK study of the early signs of Parkinson's in a highly diverse population.
Date
Researchers in Norway have published results from an early stage clinical study looking at the potential of a dietary supplement for people with Parkinson's.
Date
Researchers, including scientists from Queen's University Belfast, have discovered that people with Parkinson's who eat more flavonoids may have a longer life expectancy.
Date
Researchers in the Netherlands discover that regular exercise may improve Parkinson’s symptoms by creating connections between areas of the brain affected by the condition.
Date
We’ve teamed up with leading patient engagement organisations COUCH Health and Egality Health to make Parkinson’s research more accessible, relevant and inclusive.
Date
If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Date
Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
Date
We’re investing in research into inflammation that could help develop drugs that slow the progression of Parkinson’s, something no current medication can do.